The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACLARIS THERAPEUTICS INC COM 00461U105 63,347,750 11,975,000 SH SOLE 0 0 11,975,000
ATEA PHARMACEUTICALS INC COM 04683R106 32,328,335 6,952,330 SH SOLE 0 0 6,952,330
CONNECT BIOPHARMA HLDGS LTD SHS G23549101 1,364,423 573,287 SH SOLE 0 0 573,287
CORE SCIENTIFIC INC NEW COM 21874A106 298,000 800 SH Put SOLE 0 0 800
ENGENE THERAPEUTICS INC COM *A* 29286X101 11,538,941 6,669,908 SH SOLE 0 0 6,669,908
IMAGENEBIO INC COM 45175G207 1,184,307 200,730 SH SOLE 0 0 200,730
JANUX THERAPEUTICS INC COM 47103J105 2,380,201 154,961 SH SOLE 0 0 154,961
KRAFT HEINZ CO COM 500754106 10,983,300 465,000 SH SOLE 0 0 465,000
CARMAX INC COM 143130102 9,123,525 172,500 SH SOLE 0 0 172,500
OUTSET MED INC COM NEW 690145206 10,885,108 2,519,701 SH SOLE 0 0 2,519,701
ORAMED PHARMACEUTICALS INC COM NEW 68403P203 4,166,754 866,269 SH SOLE 0 0 866,269
PLIANT THERAPEUTICS INC COM 729139105 1,762,596 1,546,137 SH SOLE 0 0 1,546,137
PMV PHARMACEUTICALS INC COM 69353Y103 7,142,200 5,330,000 SH SOLE 0 0 5,330,000
TARGET CORP COM 87612E106 4,897,875 37,500 SH SOLE 0 0 37,500
INSTIL BIO INC COM NEW 45783C200 4,964,664 645,600 SH SOLE 0 0 645,600
TILLYS INC CL A 886885102 9,030,000 2,150,000 SH SOLE 0 0 2,150,000
TESLA INC COM 88160R101 270,000 375 SH Put SOLE 0 0 375
WALMART INC COM 931142103 386,088 335 SH Put SOLE 0 0 335